BRCA1 and breast neoplasm: Breast tumors carrying BRCA1 mutations are considered to be sensitive to inhibitors of poly (ADP-ribose) polymerases (PARPs) that are nuclear enzymes implicated in cellular responses to DNA injury provoked by genotoxic stress (33).